Business
Viemed Healthcare Announces Record 2024 Financial Results
LAFAYETTE, La., March 10, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three months and year ended December 31, 2024, and issued its guidance for the full year ending December 31, 2025. Fourth Quarter and Full Year Operational Highlights (all dollar amounts are USD): Net revenues for the quar
About this update from Viemed Healthcare, Inc.
[{"type":"image","alt":"Viemed Healthcare, Inc.","displaySize":"","headline":null,"caption":"Viemed Healthcare, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":125,"url":"https://media.zenfs.com/en/globenewswire.com/cc5a792726a74b70b3da7b0ed0a2cba1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/mHuz1fZsfOPljMggXtiyQg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE3NTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/cc5a792726a74b70b3da7b0ed0a2cba1","width":300,"height":125}},"lazy":false},{"type":"text","content":"LAFAYETTE, La., March 10, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three months and year ended December 31, 2024, and issued its guidance for the full year ending December 31, 2025.","length":392,"tagName":"p"},{"type":"text","content":"Fourth Quarter and Full Year Operational Highlights (all dollar amounts are USD):","length":81,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Net revenues for the quarter ended December 31, 2024 reached a new Company record of $60.7 million representing an increase of $10.0 million, or 20%, over net revenues reported for the comparable quarter ended December 31, 2023. Total net revenues for the year ended December 31, 2024 were a record-breaking $224.3 million, an increase of $41.2 million, or 23%, over the year ended December 31, 2023.","length":415,"tagName":"p"}]},{"val":[{"type":"text","content":"Net income attributable to Viemed for the quarter ended December 31, 2024 totaled $4.3 million, or $0.10 per diluted share, an increase of 24% over net income attributable to Viemed reported for the comparable quarter ended December 31, 2023. Net income attributable to Viemed for the year ended December 31, 2024 totaled $11.3 million, or $0.28 per diluted share, an increase of 10% over the year ended December 31, 2023, marking the Company's eighth consecutive year of positive net income.","length":506,"tagName":"p"}]},{"val":[{"type":"text","content":"The Company increased its ventilator patient count to 11,795 as of December 31, 2024, an increase of 14% over December 31, 2023, and a 4% sequential increase from ...